+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Viral Vector"

From
Vaccine Contract Manufacturing Market Report 2023-2033 - Product Thumbnail Image

Vaccine Contract Manufacturing Market Report 2023-2033

  • Report
  • May 2023
  • 375 Pages
  • Global
From
Retinal Gene Therapy Market Report 2024-2034 - Product Thumbnail Image

Retinal Gene Therapy Market Report 2024-2034

  • Report
  • July 2024
  • 235 Pages
  • Global
From
The 2022 World Market for Vaccines - Product Thumbnail Image

The 2022 World Market for Vaccines

  • Report
  • October 2022
  • 194 Pages
  • Global
From
From
Cell and Gene Therapy World Market and Market Potential - Product Thumbnail Image

Cell and Gene Therapy World Market and Market Potential

  • Report
  • February 2022
  • 272 Pages
  • Global
From
From
From
From
From
U.S. Gene Therapy Market - Industry Outlook & Forecast 2022-2027 - Product Thumbnail Image

U.S. Gene Therapy Market - Industry Outlook & Forecast 2022-2027

  • Report
  • March 2022
  • 208 Pages
  • United States
From
Viral Vector and Plasmid DNA: Technologies and Global Markets - Product Thumbnail Image

Viral Vector and Plasmid DNA: Technologies and Global Markets

  • Report
  • March 2024
  • 128 Pages
  • Global
From
3D Cell Cultures: Technologies and Global Markets - Product Thumbnail Image

3D Cell Cultures: Technologies and Global Markets

  • Report
  • February 2024
  • 442 Pages
  • Global
From
RNAi Drug Delivery: Technologies and Global Markets - Product Thumbnail Image

RNAi Drug Delivery: Technologies and Global Markets

  • Report
  • August 2023
  • 141 Pages
  • Global
From
Loading Indicator

The Viral Vector market is a subset of the biotechnology industry that focuses on the development and production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases. Viral vectors are produced through a variety of methods, including recombinant DNA technology, synthetic biology, and cell-based systems. The production of viral vectors requires specialized equipment and expertise, making it a highly specialized field. The Viral Vector market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Novartis, Merck, Pfizer, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the production of viral vectors, such as Viralgen, Oxford BioMedica, and Vigene Biosciences. Show Less Read more